At Faeth, we believe that the use of metabolism and precision nutrition will join surgery, radiotherapy, small molecules (e.g. chemotherapy, targeted therapies), and biologics (e.g. immunotherapy, antibodies) as a foundational treatment for cancer.
Faeth is a data-driven, evidence-based company with a deep mechanistic understanding of the way that dietary nutrients influence tumor growth and cancer treatment. We are fully focused on matching specific diets with tumor genotypes and treatment regimens to improve the outcomes of cancer therapy, and we’re in clinical trials now.
Using metabolism and precision nutrition to starve cancer of the nutrients it needs to grow and resist treatment has the potential to transform the efficacy of conventional cancer therapies.
Our mission is to help every cancer patient use the power inside them to beat their cancer with world-leading science and precision nutrition.
Congratulations to our World Economic Forum Technology Pioneers 2020
Sanjeev Krishnan, S2G Ventures Managing Director and CIO, will ...Connecting Technology and Business to Create Healthy, Resilient Food Systems.